Flavaglines Alleviate Doxorubicin Cardiotoxicity: Implication of Hsp27

Flavaglines Alleviate Doxorubicin Cardiotoxicity: Implication of Hsp27

Bibliographic Details
Main Authors:	Bernard, Yohann, Ribeiro, Nigel, Thuaud, Frédéric, Türkeri, Gülen, Dirr, Ronan, Boulberdaa, Mounia, Nebigil, Canan G., Désaubry, Laurent
Format:	Online
Language:	English
Published:	Public Library of Science 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204970/

Similar Items

FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity
by: Qureshi, Rehana, et al.
Published: (2015)

Prokineticin Receptor‐1 Is a New Regulator of Endothelial Insulin Uptake and Capillary Formation to Control Insulin Sensitivity and Cardiovascular and Kidney Functions
by: Dormishian, Mojdeh, et al.
Published: (2013)

N-[3a-(4-Bromophenyl)-8b-hydroxy-6,8-dimethoxy-3-phenyl-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-1-yl]formamide monohydrate
by: Aubert, Emmanuel, et al.
Published: (2012)

Discovery of GPCR ligands for probing signal transduction pathways
by: Brogi, Simone, et al.
Published: (2014)

Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
by: Stilinović, Nebojša, et al.
Published: (2012)

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
by: Hole, Lisa Drange, et al.
Published: (2014)

A Novel Insight into the Cardiotoxicity of Antineoplastic Drug Doxorubicin
by: Heger, Zbynek, et al.
Published: (2013)

Morphine Enhances Doxorubicin-Induced Cardiotoxicity in the Rat
by: Hole, Lisa Drange, et al.
Published: (2014)

SYKT Alleviates Doxorubicin-Induced Cardiotoxicity via Modulating ROS-Mediated p53 and MAPK Signal Pathways
by: Ting Chen, et al.
Published: (2018-01-01)

Flavaglines Stimulate Transient Receptor Potential Melastatin Type 6 (TRPM6) Channel Activity
by: Blanchard, Maxime G., et al.
Published: (2015)

Prokineticin Receptor 1 as a Novel Suppressor of Preadipocyte Proliferation and Differentiation to Control Obesity
by: Szatkowski, Cécilia, et al.
Published: (2013)

Prokineticin receptor-1 signaling promotes Epicardial to Mesenchymal Transition during heart development
by: Arora, Himanshu, et al.
Published: (2016)

Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro
by: Sun, Jing, et al.
Published: (2013)

The Role of Nitric Oxide in Doxorubicin-Induced Cardiotoxicity: Experimental Study
by: Bahadır, Ayşenur, et al.
Published: (2014)

Nrf2 Deficiency Exaggerates Doxorubicin-Induced Cardiotoxicity and Cardiac Dysfunction
by: Li, Siying, et al.
Published: (2014)

Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
by: Todorova, Valentina K., et al.
Published: (2016)

Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes
by: Maillet, Agnes, et al.
Published: (2016)

Cardioprotective Potentials of Plant-Derived Small Molecules against Doxorubicin Associated Cardiotoxicity
by: Ojha, Shreesh, et al.
Published: (2016)

Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity
by: Gu, Jun, et al.
Published: (2015)

In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity
by: Chen, Chih-Tai, et al.
Published: (2015)

The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity
by: Akolkar, Gauri, et al.
Published: (2015)

CMR myocardial tissue characterization in a mouse model of doxorubicin-induced cardiotoxicity
by: Allen, Bradley D, et al.
Published: (2015)

Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity
by: Maccarinelli, Federica, et al.
Published: (2014)

Hsp27-Actin Interaction
by: Graceffa, Philip
Published: (2011)

Proteomic Profiling Reveals That Resveratrol Inhibits HSP27 Expression and Sensitizes Breast Cancer Cells to Doxorubicin Therapy
by: Díaz-Chávez, José, et al.
Published: (2013)

Discovery and Cardioprotective Effects of the First Non-Peptide Agonists of the G Protein-Coupled Prokineticin Receptor-1
by: Gasser, Adeline, et al.
Published: (2015)

HSP27 Alleviates Cardiac Aging in Mice via a Mechanism Involving Antioxidation and Mitophagy Activation
by: Lin, Shenglan, et al.
Published: (2016)

Biomimetic Kinetic Resolution: Highly Enantio- and Diastereoselective Transfer Hydrogenation of Aglain Ketones To Access Flavagline Natural Products
by: Stone, Steven D., et al.
Published: (2014)

Plasmodium falciparum Hsp70-z, an Hsp110 homologue, exhibits independent chaperone activity and interacts with Hsp70-1 in a nucleotide-dependent fashion
by: Zininga, Tawanda, et al.
Published: (2016)

HSP27 and HSP70 expression in squamous cell carcinoma: An immunohistochemical study
by: Deyhimi, Parviz, et al.
Published: (2012)

Overexpression, Purification and Characterisation of the Plasmodium falciparum Hsp70-z (PfHsp70-z) Protein
by: Zininga, Tawanda, et al.
Published: (2015)

Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target
by: Vidyasagar, Aparna, et al.
Published: (2012)

HSP-90 Inhibitor Ganetespib is Synergistic with Doxorubicin in Small Cell Lung Cancer
by: Lai, Chien-Hao, et al.
Published: (2013)

Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer
by: Gu, Yue, et al.
Published: (2016)

Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo
by: Xu, Yang, et al.
Published: (2011)

Correction: Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo
by: Xu, Yang, et al.
Published: (2012)

Desferrioxamine Attenuates Doxorubicin-Induced Acute Cardiotoxicity through TFG-β/Smad p53 Pathway in Rat Model
by: Al-Shabanah, Othman A., et al.
Published: (2012)

Differential roles of nitric oxide synthase isozymes in cardiotoxicity and mortality following chronic doxorubicin treatment in mice
by: Deng, Shiwei, et al.
Published: (2009)

Combined effects of p-coumaric acid and naringenin against doxorubicin-induced cardiotoxicity in rats
by: Shiromwar, Shruti S., et al.
Published: (2011)

Identification of protein targets underlying dietary nitrate-induced protection against doxorubicin cardiotoxicity
by: Xi, Lei, et al.
Published: (2011)